SC 13G Filing

Company

TherapeuticsMD, Inc.

Filed

November 12, 2024

Accession Number

0001600136-24-000007

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →